ExpreS2ion Biotech Holding
2.34 SEK
-20.41 %
Less than 1K followers
EXPRS2
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ExpreS2ion Biotech Holding
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.5 | 0.6 | 3.0 | 1.3 | 1.5 | 0.4 | 0.4 | 3.7 |
| EBITDA | -12.7 | -19.3 | -104.2 | -12.3 | -11.3 | -9.4 | -9.8 | -42.8 |
| EBIT | -13.1 | -19.7 | -67.7 | -12.7 | -11.7 | -9.7 | -10.2 | -44.3 |
| EBIT-% | -2,854.3 % | -3,283.3 % | -2,249.2 % | -951.9 % | -758.4 % | -2,760.9 % | -2,340.2 % | -1,210.6 % |
| Profit before taxes | -13.0 | -19.4 | -44.6 | -14.0 | -11.5 | -9.8 | -10.0 | -44.2 |
| Net income | -10.5 | -15.6 | -36.4 | -11.4 | -10.0 | -8.4 | -8.2 | -38.1 |